June 20, 2013 |
WASHINGTON - The Food and Drug Administration on Wednesday for the first time approved a type of diagnostic test that will allow doctors to determine what kind of hepatitis C virus a chronically infected patient has, and tailor treatments based on that genetic type. No vaccine exists for the hepatitis C virus, or HCV, the most common blood-borne infection in the country. HCV infects about 3.2 million people in the U.S and leads to the death of 15,000 people annually. "Hepatitis C is known as the silent killer, as many of the symptoms go unnoticed," HIV and viral hepatitis expert Carol Brosgart, professor of medicine at UC San Francisco, said in a statement.
June 10, 2013 |
Why is it seemingly such a secret what the cause of death was of Richard Ramirez, the "Night Stalker"? With everything the public knows about his crimes, his weird beliefs and his many victims, for some reason this is being kept from open knowledge, at least for now. All authorities will say is that he died of natural causes. The tabloids and gossip sites are reporting that it was hepatitis C; a handful contend that he turned bright green shortly before his death. But why are people left to guess whether these reports are true rather than simply receive a short, official statement?
May 8, 2013 |
Half of all patients who have tested positive for hepatitis C have not had follow-up testing to see if they are still infected, according to the Centers for Disease Control and Prevention. That means many people are living with the disease and not receiving the necessary treatment to prevent health problems, officials said this week. Hepatitis C is the leading cause of cirrhosis and liver cancer and is the most common reason for liver transplants in the United States. The findings prompted the CDC to issue new guidelines urging healthcare providers to do a follow-up test on anyone who tests positive to an hepatitis C antibody test, which determines whether someone has ever been infected.
April 18, 2013 |
Dozens of Oklahoma dental patients have been diagnosed with hepatitis C and at least one case of HIV, state health officials said Thursday, four weeks after finding a multitude of health code violations, including rusty tools, at a dental practice in Tulsa. Authorities said they were still determining whether the infections were connected with unsanitary practices at W. Scott Harrington's two offices in Tulsa and a Tulsa suburb, which prompted officials to notify 7,000 of the dentist's patients.
March 29, 2013 |
Oklahoma health officials on Saturday begin testing dental patients in the Tulsa area for a variety of blood-borne viruses that cause hepatitis and AIDS, a precautionary measure to deal with what officials call the largest such incident in the state's history. More than 7,000 patients of Dr. W. Scott Harrington will be receiving letters urging them to seek free blood tests for hepatitis B, hepatitis C and HIV, the virus that causes AIDS. State officials have alleged a variety of unsafe practices, including using dirty equipment and allowing unlicensed workers to perform blood-related procedures, such as sedation, at clinics the dentist operated.
March 27, 2013 |
In findings that may represent a breakthrough in the treatment of hepatitis C infection, researchers have reported that weekly injections of an experimental medication that denies the virus a foothold in the liver substantially drove down subjects' viral loads after five weeks of treatment. Fourteen weeks after the injections ended, researchers found that five of 18 infected subjects getting the medication's higher doses showed no detectable trace of infection. The new study describes a treatment approach that could outsmart the hepatitis C virus's penchant for developing resistance to existing drugs and "provide curative therapy to a large proportion" of the 170 million people in the world who are infected with the virus, wrote Harvard University physician Dr. Judy Lieberman and Dr. Peter Sarnow of Stanford University.